510(k) K991083

RLP CHOLESTEROL IMMUNOSEPARATION ASSAY by Otsuka Pharmaceutical Co., Ltd. — Product Code CHH

K991083 is an FDA 510(k) premarket notification submitted by Otsuka Pharmaceutical Co., Ltd. for the device "RLP CHOLESTEROL IMMUNOSEPARATION ASSAY". The FDA issued a decision of Substantially Equivalent on Aug 20, 1999. The device falls under product code CHH (Enzymatic Esterase--Oxidase, Cholesterol), a Class I device regulated under 21 CFR 862.1175. Otsuka Pharmaceutical Co., Ltd. has 5 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Aug 20, 1999
Date Received
Mar 31, 1999
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Enzymatic Esterase--Oxidase, Cholesterol
Device Class
Class I
Regulation Number
862.1175
Review Panel
CH
Submission Type
510(k) Exempt

Need the full FDA record for Otsuka Pharmaceutical Co., Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K991083. Report a data issue: hello@regdatalab.com.